SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000039
Filing Date
2021-03-02
Accepted
2021-03-02 15:34:18
Documents
5
Period of Report
2021-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clnh030121form8k.htm 8-K 145823
2 EXHIBIT 2.1 ex2_1.htm EX-2.1 627993
3 EXHIBIT 2.2 ex2_2.htm EX-2.2 165570
4 EXHIBIT 2.3 ex2_3.htm EX-2.3 589629
5 EXHIBIT 99.1 ex99_1.htm EX-99.1 18908
  Complete submission text file 0001607062-21-000039.txt   1549614
Mailing Address 55 IVAN ALLEN JR. BLVD NW #875 ATLANTA GA 30308
Business Address 55 IVAN ALLEN JR. BLVD NW #875 ATLANTA GA 30308 631-670-6777
Clinigence Holdings, Inc. (Filer) CIK: 0001479681 (see all company filings)

IRS No.: 113363609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53862 | Film No.: 21703202
SIC: 7389 Services-Business Services, NEC
Office of Trade & Services